PrimeRFP SCOUT · Federal Contract Profile

Emes2 Pharmaceuticals (L9BAWRKDMLD4)Federal contracts · 1 recompete

Emes2 Pharmaceuticals holds $205K in federal volume across 18 award actions, with 67% at Department of Health and Human Services (HHS). SCOUT tracks 1 incumbent recompete — an estimated $118K returning to market over the next 24 months (Low exposure). Primary work: All Other Support Services (100% prime). Obligations are up 11% year over year.

$205K
Federal Volume
1
Recompetes (24mo)
HHS
Top Agency · 67% firm-wide
18
Award Actions

Choose one — this changes what we ask next

Score my firm against Emes2 Pharmaceuticals

One email. We send the overlap and watch their recompetes.

Choose one — this changes what we ask next

Data through · refreshed monthly · window Sep 2025 – Sep 2026

Why are you looking at Emes2 Pharmaceuticals?

Score my firm against Emes2 Pharmaceuticals

One email. We send the overlap and watch their recompetes.

What they do

Capability

Service lines

ALL OTHER SUPPORT SERVICES

Work mix: 100% prime · 0% sub · primary NAICS 562211 / PSC P100 SALVAGE- PREPARATION AND DISPOSAL OF EXCESS/SURPLUS PROPERTY

Recompete exposure: Low · 1 in 24mo

Emes2 Pharmaceuticals has an estimated $118K in contracts returning to market over the next 24 months.

Part of the EMES2 PHARMACEUTICALS LLC corporate family · 2 entities
Metrics basis: local_db
Recompete exposure & trajectory

Recompete exposure

Low

Emes2 Pharmaceuticals has an estimated $118K in contracts returning to market over the next 24 months.

Trajectory
▲ Expanding+11% YoYFY2025 vs FY2024
'23
'24
'25
“SCOUT saves the hours of analysis that capture and proposal teams cannot afford to lose by delivering analyzed intelligence. Incumbent history, competitive positioning, and agency buying patterns get synthesized into…”
— Gwyne Taylor, Tailored Global
Explore another company
Don’t see your company?

Enter your company name and we'll build the page.

Query this company live in SCOUT via MCP — personalized displacement scoring, alerts, and capture workflow. Learn about SCOUT MCP →

Frequently asked questions

What federal contracts does Emes2 Pharmaceuticals hold?

Emes2 Pharmaceuticals (UEI L9BAWRKDMLD4) shows $205K across 18 award actions in SCOUT’s public USASpending-backed profile, with Department of Health and Human Services (HHS) as the top buying agency. Totals cover federal prime awards ≥$100K in the rolling window.

How much in federal contracts does Emes2 Pharmaceuticals have?

Emes2 Pharmaceuticals shows $205K across 18 award actions. SCOUT tracks 1 incumbent recompetes ($118K) returning to market in the next 24 months.

Which agencies does Emes2 Pharmaceuticals work with?

Emes2 Pharmaceuticals’s firm-wide obligated mix is led by Department of Health and Human Services (HHS) (67%), Department of Veterans Affairs (VA) (23%), Department of Justice (DOJ) (11%).

What is the UEI for Emes2 Pharmaceuticals?

The Unique Entity ID (UEI) for Emes2 Pharmaceuticals is L9BAWRKDMLD4.

Does Emes2 Pharmaceuticals have contracts coming up for recompete?

Yes — SCOUT tracks 1 incumbent recompete in the next 24 months (Low exposure). Open the recompete section on this page for PIID-level timing.

Ten of these with the durability read on each: the FY27 Sprint Pack, $2,800 through Sept 30.

The Pack is ten Pursuit Analyses in a 12-month balance. Delivery is 48 business hours. Start with the free Exposure Check if you want the list first.

Get the free Exposure Check

No card · under a minute · then the Sprint menu

See Tactics on the pricing page

Scout Tactics is $290 a month, with the teaming tools on. It is not sold on this page.

Compare plans

Data: Showing contracts ≥ $100K from federal procurement records (FPDS-NG, SAM.gov, and related repositories), normalized by PrimeRFP SCOUT. Each row keyed by Award ID (PIID); task orders appear as independent rows.

Sources: USASpending, FPDS, SAM.gov · Data shown is public-record; analysis by PrimeRFP SCOUT. Corpus refreshed Sep 10, 2026. Profile snapshot Aug 19, 2026.
primerfp.com/intel/company/emes2-pharmaceuticals-llc